X-linked agammaglobulinemia (XLA): A genetic tyrosine kinase (Btk) disease

BioEssays

Volumn 18, Issue 10, 1996, Pages 825-834

  Mattsson, Pekka T ^a,b,c   Vihinen, Mauno ^d   Smith, C I Edvard ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF TURKU   (Finland)

^d UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA;

EID: 0030272507     PISSN: 02659247     EISSN: None     Source Type: Journal    
DOI: 10.1002/bies.950181009     Document Type: Review

References (84)

1. Bruton, O.C. (1952). Agammaglobulinemia. Pediatrics 9, 722-727.
2. Rosen, F.S., Cooper, M.D. and Wedgwood, R.J.P. (1984). The primary immunodeficiencies (1). N. Engl. J. Med. 311, 235-242.
3. Rosen, F.S., Cooper, M.D. and Wedgwood, R.J.P. (1995). The primary immunodeficiencies. N. Engl. J. Med. 333, 431-440.
4. Good, R.A. and Zak, S.J. (1956). Disturbances in gamma globulin synthesis as 'experiments of nature'. Pediatrics 18, 109-149.
5. Lederman, H.M. and Winkelstein, J.A. (1985). X-linked agammaglobulinemia: An analysis of 96 patients. Medicine (Baltimore) 64, 145-156.
6. Sideras, P. and Smith, C.I.E. (1995). Molecular and cellular aspects of X-linked agammaglobulinemia. Adv. Immunol. 59, 135-223.
7. Smith, C.I.E. and Notarangelo, L.D. (1996). Molecular basis for X-linked immunodeficiencies. Adv. Genet. (in press).
8. Conley, M.E. et al. (1986). Expression of the gene defect in X-linked agammaglobulinemia. N. Engl. J. Med. 315, 564-567.
9. Vetrie, D. et al. (1993). The gene involved in X-linked agammaglobulinemia is a member of the src family of the protein-tyrosine kinases. Nature 361, 226-233.
10. Tsukada, S. et al. (1993). Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia. Cell 72, 279-290.
11. Thomas, J.D., Sideras, P., Smith, C.I.E., Vořechovský, I., Chapman, V. and Paul, W.E. (1993). Colocalisation of X-linked agammaglobulinemia and X-linked immunodeficiency genes. Science 261, 355-358.
12. Rawlings, D. et al. (1993). Mutation of unique region of Bruton's tyrosine kinase in immunodeficient XID mice. Science 261, 358-361.
13. Mano, H. et al. (1993). Expression of a novel form of Tec kinase in hematopoietic cells and mapping of the gene to chromosome 5 near Kit. Oncogene 8, 417-424.
14. Siliciano, L.D., Morrow, T.A. and Desiderio, S.V. (1992). Itk, a T cell specific tyrosine kinase gene inducible by interleukin 2. Proc. Natl Acad. Sci. USA 89, 11194-11198.
15. Heyeck, S.D. and Berg, L.J. (1993). Developmental regulation of a murine T-cell-specific tyrosine kinase gene Tsk. Proc. Natl Acad. Sci. USA 90, 669-673.
16. Yamada, N. et al. (1993). Structure and expression of novel protein-tyrosine kinases, emb and emt, in hematopoietic cells. Biochem. Biophys. Res. Commun. 192, 231-237.
17. Tamagnone, L. et al. (1994). BMX/TXK, a novel cytoplasmic tyrosine kinase gene of the BTK/ITK/TEC family located in chromosome Xp22.2. Oncogene 9, 3683-3688.
18. Smith, C.I.E. et al. (1994). X-linked agammaglobulinemia and other immunoglobulin deficiencies. Immunol. Rev. 138, 159-183.
19. Vihinen, M., Nilsson, L. and Smith, C.I.E. (1994). Tec homology (TH) adjacent to the PH domain. FEBS Lett. 350, 263-265.
20. Haire, R.N., Ohta, Y., Lewis, J.E., Fu, S.M., Kroisel, P. and Litman, G.W. (1994). TXK, a novel human tyrosine kinase expressed in T cells shares sequence identity with Tec family kinases and maps to 4p12. Hum. Mol. Genet. 3, 897-901.
21. Hu, Q. et al. (1995). Identification of RIk, a novel protein tyrosine kinase with predominant expression in the T cell lineage. J. Biol. Chem. 270, 1928-1934.
22. Smith, C.I.E. et al. (1994). Expression of Bruton's agammaglobulinemia tyrosine kinase gene, BTK, is selectively down-regulated in T lymphocytes and plasma cells. J. Immunol. 152, 557-565.
23. Vihinen, M. and Smith, C.I.E. (1996). Structural aspects of signal transduction in B cells. Crit. Rev. Immunol. (in press).
24. Kwan, S.-P., Kunkel, L., Bruns, G., Wedgwood, R.J., Latt, S. and Rosen, F.S. (1986). Mapping of the X-linked agammaglobulinemia locus by use of restriction fragment-length polymorphism. J. Clin. Invest. 77, 649-652.
25. Ott, J., Mensink, E.J.B.M., Thompson, A., Schot, I.D. and Schuurman, R.K.B. (1986). Heterogeneity in the map distance between X-linked agammaglobulinemia and a map of nine RFPL loci. Hum. Genet. 74, 280-283.
26. Kwan, S.-P. et al. (1990). Identification of a closely linked DNA marker, DXS178, to further refine the X-linked agammaglobulinemia locus. Genomics 6, 238-242.
27. Vořechovský, I. et al. (1994). Isolation of cosmid and cDNA clones in the region surrounding the BTK gene at Xq21.3-q22. Genomics 21, 517-524.
28. Ohta, Y. et al. (1994). Genomic organization and structure of Bruton agammaglobulinemia tyrosine kinase: Localization of mutations associated with varied clinical presentations and course in X-linked agammaglobulinemia. Proc. Natl Acad. Sci. USA 91, 9062-9066.
29. Hagemann, T.L., Chen, Y., Rosen, F.S. and Kwan, S.-P. (1994). The genomic structure of the BTK gene and its use in direct DNA sequence analysis for mutations in patients with X-linked agammaglobulinemia. Hum. Mol. Genet. 3, 1743-1749.
30. Sideras, P. et al. (1994). Genomic organisation of mouse and human Bruton's agammaglobulinemia tyrosine kinase (Btk) loci. J. Immunol. 153, 5607-5617.
31. Rohrer, J., Parolino, O., Belmont, J.W. and Conley, M.E. (1994). The genomic structure of human Btk, the defective gene in X-linked agammaglobulinemia. Immunogenet. 40, 319-324.
32. Vihinen, M. et al. (1995). BTKbase, a database of XLA-causing mutations. Immunol. Today, 16, 460-465.
33. Vihinen, M. et al. (1996). BTKbase, mutation database for X-linked agammaglobulinemia (XLA). Nucl. Acids Res. 24, 160-165.
34. de Weers, M. et al. (1994). B cell antigen receptor stimulation activates the human Bruton's tyrosine kinase, which is deficient in X-linked agammaglobulinemia. J. Biol. Chem. 269, 23857-23860.
35. Aoki, Y., Isselbacher, K.J. and Pillai, S. (1994). Bruton tyrosine kinase is tyrosine phosphorylated and activated in pre-B lymphocytes and receptor-ligated B cells. Proc. Natl Acad. Sci. USA. 91, 10606-10609.
36. Tsukada, S., Simon, M.I., Witte, O.N. and Kalz, A. (1994). Binding of βγ subunits of heterotrimeric G-proteins to the PH domain of Bruton tyrosine kinase. Proc. Natl Acad. Sci. USA 91, 11256-11260.
37. Harlan, J.E., Hajduk, P.J., Yoon, H.S. and Fesik, S.W. (1994). Pleckstrin homology domains bind to phosphatidylinositol-4,5-bisphosphate. Nature 371, 168-170.
38. Harlan, J.E., Yoon, H.S. Hajduk, P.J. and Fesik, S.W. (1995). Structural characterization of the interaction between a pleckstrin homology domain and phosphatidylinositol-4,5-bisphosphate. Biochemistry 34, 9859-9864.
39. Fushman, D., Cahill, S., Lemmon, M.A., Schlessinger, J. and Cowburn, D. (1995). Solution structure of pleckstrin homology domain of dynamin by heteronuclear NMR spectroscopy. Proc. Natl Acad. Sci. USA 92, 816-820.
40. Hyvönen, M., Macias, M.J., Nilges, M., Oschkinat, H., Saraste, M. and Wilmanns, M. (1995). Structure of the binding site for inositol phosphates in a PH domain. EMBO J. 14, 4676-4685.
41. Ferguson, K.M., Lemmon, M.A., Sclessinger, J. and Sigler, P.B. (1995). Structure of the high affinity complex of inositol trisphosphate with a phospholipase C pleckstrin homology domain. Cell 83, 1037-1046.
42. Rawlings, D.J. et al. (1996). Activation of the BTK by a phosphorylation mechanism initiated by SRC family kinases. Science 271, 822-825.
43. Langhans-Rajasekaran, S.A., Wan, Y. and Huang, X.-Y. (1996). Activation of Tsk and Btk tyrosine kinases by G protein βγ subunits. Proc. Natl Acad. Sci. USA 92, 8601-8605.
44. Yao, L., Kawakami, Y. and Kawakami, T. (1994). The pleckstrin homology domain of Bruton tyrosine kinase interacts with protein kinase C. Proc. Natl Acad. Sci. USA 91, 9175-9179.
45. Konishi, H., Shinomura, T., Kuroda, S., Ono, Y. and Kikkawa, U. (1994). Molecular cloning of rat Rac protein kinase a and β and their association with protein kinase C ζ. Biochem. Biophys. Res. Commun. 205, 817-825.
46. Konishi, H., Kuroda, S. and Kikkawa, U. (1994). The pleckstrin homology domain of Ras protein kinase associates with the regulatory domain of protein kinase C ζ. Biochem. Biophys. Res. Commun. 205, 1770-1775.
47. Konishi, H. et al. (1995). Molecular cloning and characterization of a new member of the Rac protein kinase family: Association of the pleckstrin homology domain of three types of Rac protein kinase with protein kinase C subspecies and βγ subunits of G proteins. Biochem. Biophys. Res. Commun. 216, 526-534.
48. Touhara, K., Inglese, J., Pitcher, J.A., Shaw, G. and Lefkowitz, R.J. (1994). Binding of G protein βγ-subunits to pleckstrin homology domains. J. Biol. Chem. 269, 10217-10220.
49. Cheng, G., Ye, Z.-S. and Baltimore, D. (1994). Binding of Bruton's tyrosine kinase to Fyn, Lyn, or Hck through a Src homology 3 domain-mediated interaction. Proc. Natl Acad. Sci. USA 91, 8152-8188.
50. Yang, W., Malek, S.N. and Desiderio, S. (1995). An SH3-binding site conserved in Bruton's tyrosine kinases mediates specific protein interactions in vitro and in vivo. J. Biol. Chem. 270, 20832-20840.
51. Alexandropoulos, K., Cheng, G. and Baltimore, D. (1995). Proline-rich sequences that bind to Src homology 3 domains with individual specificities. Proc. Natl Acad. Sci. USA 92, 3110-3114.
52. Pawson, T. (1995). Protein modules and signalling networks. Nature 373, 573-580.
53. Cohen, G.B., Ren, R. and Baltimore, D. (1995). Modular binding domains in signal transduction proteins. Cell 80, 238-248.
54. Cory, G.O.C., Lovering, R.C., Hinshelwood, S., MacCarthy-Morrogh, L., Levinsky, R.J. and Kinnon, C. (1995). The protein product of the c-cbl protooncogene is phosphorylated after B cell receptor stimulation and binds the SH3 domain of Bruton's tyrosine kinase. J. Exp. Med. 182, 611-615.
55. Park, H. et al. (1996). Regulation of Btk function by a major autophosphorylation site within the SH3 domain. Immunity 4, 515-525.
56. Mahajan, S., Fargnoll, J., Burkhardt, A.L., Kut, S.A., Saouf, S.J. and Bolen, J.D. (1995). Src family protein kinases induce autoactivation of Bruton's tyrosine kinase. Mol. Cell. Biol. 15, 5304-5311.
57. Saouf, S.J. et al. (1994). Temporal differences in the activation of three classes of non-transmembrane protein tyrosine kinases following B-cell antigen receptor surface engagement. Proc. Natl Acad. Sci. USA 91, 9524-9528.
58. Matsuda, T. et al. (1995). Association and activation of Btk and Tec tyrosine kinases by gp130, a signal transducer of the interleukin-6 family of cytokines. Blood 85, 627-633.
59. Vihinen, M. et al. (1995). Structural basis for pleckstrin homology domain mutations in X-linked agammaglobulinemia. Biochemistry 34, 1475-1481.
60. Zheng, J., Cahill, S.M., Lemmon, M.A., Fushman, D., Sclessinger, J. and Cowburn, D. (1996). Identification of the binding site for acidic phospholipids on the PH domain of dynamin: Implications for stimulation of GTPase activity. J. Mol. Biol. 255, 14-21.
61. Li, T., Tsukada, S., Satterthwaite, A., Havlik, M.H., Park, H., Takatsu, K. and Witte, O.N. (1995). Activation of Bruton's tyrosine kinase (BTK) by a point mutation in its pleckstrin homology (PH) domain. Immunity 2, 451-460.
62. Koch, W.J., Inglese, J., Stone, W.C. and Lefkowitz, R.J. (1993). The binding site for the βγ subunits of heterotrimeric G proteins on the β-adrenergic receptor kinase. J. Biol. Chem. 268, 8256-8260.
63. βγ subunits. Biochemistry 34, 9111-9117.
64. iα1β1γ2. Cell 83, 1047-1058.
65. Lambright, D.G., Sondek, J., Bohm, A., Skiba, N.P., Hamm, H.E. and Sigler, P.B. (1996). The 2.0 Å crystal structure of a helerotrimeric G protein. Nature 379, 311-319.
66. A protein βγ dimer at 2.1 Å resolution. Nature 379, 369-374.
67. Lemmon, M.A., Ferguson, K.M. and Schlessinger, J. (1996). PH domains: Diverse sequences with a common fold recruit signaling molecules to the cell surface. Cell 85, 621-624.
68. Zhu, Q. et al. (1994). Deletion within the Src homology domain 3 of Bruton's tyrosine kinase resulting in X-linked agammaglobulinemia (XLA). J. Exp. Med. 180, 461-470.
69. Vihinen, M., Nilsson, L. and Smith, C.I.E. (1994). Structural basis of SH2 domain mutations in X-linked agammaglobulinemia. Biochem. Biophys. Res. Commun. 205, 1270-1277.
70. Feng, S., Chen, J.K., Yu, H., Simon, J.A. and Schreiber, S.L. (1994). Two binding orientations for peptides to the Src SH3 domain: Development of a general model for SH3-ligand interactions. Science 266, 1241-1247.
71. Vořechovský, I. et al. (1995). DNA-based mutation analysis of Bruton's tyrosine kinase gene in patients with X-linked agammaglobulinemia. Hum. Mol. Genet. 4, 51-58.
72. Johnson, L.N., Noble, M.E.M. and Owen, D.J. (1996). Active and inactive protein kinases: Structural basis for regulation. Cell 85, 149-158.
73. Hanks, S.K. (1991). Eukaryotic protein kinases. Curr. Opin. Struct. Biol. 1, 369-383.
74. Cox, S., Radzio-Andzeim, E. and Taylor, S.S. (1994). Domain movements in protein kinases. Curr. Opin. Struct. Biol. 4, 893-901.
75. Vihinen, M. et al. (1994). Structural basis for chromosome X-linked agammaglobulinemia: A tyrosine kinase disease. Proc. Natl. Acad. Sci. USA 91, 12803-12807.
76. Jin, H. et al. (1995). Identification of Btk mutations in 20 unrelated patients with X-linked agammaglobulinemia (XLA). Hum. Mol. Genet. 4, 693-700.
77. Maniar, H.S., Vihinen, M., Webster, A.D.B., Nilsson, L. and Smith, C.I.E. (1995). Structural basis for X-linked agammaglobulinemia (XLA). Mutations at interacting Btk residues R562, W563 and R582. Clin. Immunol. Immunopathol. 76, S198-S202.
78. Knighton, R.D., Zheng, J., Ten Eyck, L.F., Xuong, N.-H., Taylor, S.S. and Sowadski, J.M. (1991). Structure of a peptide inhibitor bound to the catalytic subunit of cyclic adenosine monophosptiate-dependent protein kinase. Science 253, 414-420.
79. 2+ adenylyl imidophosphate and inhibitor peptide PKI(5-24). EMBO J. 12, 849-859.
80. Hubbardt, S.R., Wei, L., Ellis, L. and Hendrickson, W.A. (1994). Crystal structure of the tyrosine kinase domain of the human insulin receptor. Nature 372, 746-754.
81. Kallunki, T. et al. (1994). JNK2 contains a specificity-determining region responsible for efficient c-Jun binding and phosphorylation. Genes Dev. 8, 2996-3007.
82. Khan, W.N. et al. (1995). Defective B cell development and function in Btk-deficient mice. Immunity, 3, 283-299.
83. Kernel, J.D. et al. (1995). Impaired expansion of mouse B cell progenitors lacking Btk. Immunity 3, 301-312.
84. August, A., Gibson, S., Kawakami, T., Mills, G.B. and Dupont, B. (1994). CD28 is associated with and induces the immediate tyrosine phosphorylation and activation of the Tec family kinase ITK/EMT in the human Jurkat leukemic T-cell line. Proc. Natl Acad. Sci. USA 91, 9347-9351